Ozempic Side Effects Timeline:
What to Expect Month by Month

Most people start at the lowest dose — 0.25 mg for semaglutide. This is a sub-therapeutic dose designed to let your body adjust, not to produce weight loss.

What most people feel:

• Mild nausea — reported by ~44% of semaglutide users in STEP 1. Usually peaks 1–3 days after injection, then fades. Eating smaller meals helps.
• Decreased appetite — the first hint of what GLP-1 does. Food becomes less interesting. Many describe the disappearance of "food noise" — the constant background mental chatter about eating.
• Mild fatigue — your body is adjusting to new blood sugar regulation. Usually resolves by week 2.
• Injection site reactions — small red mark, mild itching. Normal and temporary.

What most people don't feel yet: Significant weight loss. The 0.25 mg dose typically produces 0–2 lbs of loss, mostly from eating less without trying.

Still on 0.25 mg (most protocols stay here for 4 weeks). Your body is acclimating.

• Nausea improves significantly — most users report it dropping from "noticeable" to "barely there" by week 3.
• Constipation may appear — GLP-1 slows gastric emptying. Fiber, magnesium, and hydration are the standard fixes.
• Food noise continues to quiet — this is often the most psychologically impactful change. Users describe it as "silence in my head for the first time."
• Weight loss: 2–5 lbs total from start.

The jump from 0.25 to 0.5 mg is where many people feel the medication "kick in."

• Nausea may return briefly — each dose increase can retrigger GI symptoms for 3–7 days. This is normal and expected.
• Appetite suppression strengthens — some users report struggling to eat enough. This is where protein tracking becomes critical (see our muscle preservation guide).
• Energy may dip — eating less means fewer calories. Ensure you're getting at least 1,200 calories/day and adequate protein.
• Weight loss accelerates: 5–10 lbs total from start.

Your body has adapted to the medication. Most initial side effects have resolved or become manageable.

• GI symptoms stabilize — nausea is rare except around dose increases. Constipation is the most persistent complaint (managed with fiber + hydration).
• Hair thinning may begin — reported by ~5–10% of users. This is telogen effluvium caused by rapid weight loss and caloric deficit, not the medication directly. It's temporary and reverses when weight stabilizes.
• "Ozempic face" concerns — facial volume loss becomes noticeable for some. This is fat loss from the face, which happens with any significant weight loss.
• Muscle loss concern — in the STEP 1 trial, up to 40% of weight lost was lean mass. Resistance training + 0.7–1.0g protein per pound of body weight significantly reduces this.
• Weight loss: 10–20 lbs total from start. The rate varies enormously by individual.

Most side effects have resolved. The medication feels like part of your routine.

• Appetite is consistently lower — most users have found their new eating pattern. Meals are smaller, cravings are quieter.
• Plateaus may begin — weight loss slowing or stalling for 2–4 weeks is extremely common at this stage. It does not mean the medication stopped working. Body composition may still be changing even when the scale doesn't move.
• Mood effects — some users report improved mood and confidence from weight loss and health improvements. A smaller number report increased anxiety. Both are worth tracking and discussing with your prescriber.
• Weight loss: 15–30 lbs total from start, with wide individual variation.

By month 6, you're past the acute side-effect window. The question becomes: how do you sustain the progress?

• Side effects are minimal for most users. Occasional GI discomfort around rich meals. Some users report "sulfur burps" as the most persistent annoyance.
• Weight loss continues but slows — 1–2 lbs/month is typical at this stage. Some users reach their goal weight; others plateau significantly above it.
• Dose decisions — your prescriber may increase to the maximum (2.4 mg for Wegovy), hold at a maintenance dose, or begin discussing tapering.
• Muscle preservation becomes the priority — if you haven't started resistance training, start now. The metabolic cost of muscle loss compounds over time.

From the STEP 1 trial (semaglutide 2.4 mg, 68 weeks, 1,961 participants):

• Average weight loss: 14.9% of body weight (vs 2.4% placebo)
• Nausea reported by 44% (vs 18% placebo) — mostly mild to moderate, resolving by month 3
• Diarrhea: 32% (vs 16% placebo)
• Constipation: 24% (vs 11% placebo)
• Discontinuation due to side effects: 7% (meaning 93% tolerated it well enough to continue)

The key insight: most side effects are front-loaded. If you can tolerate months 1–3, months 4–12 are significantly easier.

• Eat smaller, more frequent meals — large meals on GLP-1 medications cause the worst nausea
• Stay hydrated — dehydration worsens every GI symptom
• Time your injection — many users find injecting before bed allows them to sleep through the worst nausea window
• Track your symptoms — patterns emerge that no single day can show. A bad week in month 2 feels different when you can see it's 60% better than month 1
• Prioritize protein — 0.7–1.0g per pound of body weight protects muscle. Most GLP-1 users drastically under-eat protein without tracking it